These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 8418225

  • 1. Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial.
    Cascinu S, Fedeli A, Fedeli SL, Catalano G.
    J Clin Oncol; 1993 Jan; 11(1):148-51. PubMed ID: 8418225
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study.
    Yavuz MN, Yavuz AA, Aydin F, Can G, Kavgaci H.
    Int J Radiat Oncol Biol Phys; 2002 Sep 01; 54(1):195-202. PubMed ID: 12182992
    [Abstract] [Full Text] [Related]

  • 3. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
    Topkan E, Karaoglu A.
    Oncology; 2006 Sep 01; 71(5-6):354-60. PubMed ID: 17873499
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phase I trial of the somatostatin analog octreotide acetate in the treatment of fluoropyrimidine-induced diarrhea.
    Wadler S, Haynes H, Wiernik PH.
    J Clin Oncol; 1995 Jan 01; 13(1):222-6. PubMed ID: 7799023
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Control of irinotecan-induced diarrhea by octreotide after loperamide failure.
    Barbounis V, Koumakis G, Vassilomanolakis M, Demiri M, Efremidis AP.
    Support Care Cancer; 2001 Jun 01; 9(4):258-60. PubMed ID: 11430421
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients.
    Geller RB, Gilmore CE, Dix SP, Lin LS, Topping DL, Davidson TG, Holland HK, Wingard JR.
    Am J Hematol; 1995 Nov 01; 50(3):167-72. PubMed ID: 7485077
    [Abstract] [Full Text] [Related]

  • 16. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
    Rosenoff SH.
    Eur J Cancer Care (Engl); 2004 Sep 01; 13(4):380-3. PubMed ID: 15305907
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.